News Archive

Date: 04/24/2012
Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially leading to more mastectomies over breast-conserving therapy.
Date: 04/24/2012
University of Michigan study reveals need for better screening, prevention of venous thromboembolism as outpatient surgery grows.
Date: 04/17/2012
Surgery to remove only the tumor preferable to removing entire kidneyWritten by Nicole Fawcett; and Mary Masson: contact via email or telephone 734-764-2220.
Date: 04/16/2012
When women at high risk of breast cancer viewed a customized web-based decision guide about prevention options, they were more likely to make a choice about prevention.
Date: 04/11/2012
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.
Date: 04/02/2012
Pathology evaluations done on-site cut operating time, reduced cost, study shows. Resulting in fewer women needing repeat breast cancer surgeries." />
Date: 04/02/2012
Arul M. Chinnaiyan, M.D., Ph.D., of the University of Michigan Comprehensive Cancer Center will lead the Dream Team project titled Precision Therapy for Advanced Prostate Cancer.
Date: 03/27/2012
Dr. Sofia Merajver, an expert on breast and ovarian cancer genetics, is available to discuss U.S. Supreme Court developments in Myriad Genetics case.
Date: 03/19/2012
In time for Colorectal Cancer Awareness Month, University of Michigan Comprehensive Cancer Center experts outline genetic counseling, screening and treatment strategies for colorectal cancer.
Date: 03/13/2012
Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.